News

Group News:
3/27/24 – It is very nice to see two of our laboratory’s compounds commercially available for others to explore their utility as chemical tools and drug discovery entities. They are the subject of our 2022 AAC paper (https://pubmed.ncbi.nlm.nih.gov/35972242/). Please check out the website: http://www.probechem.com/products_JSF-2659.html and http://www.probechem.com/products_JSF-2414.html

1/23/24 – We bid farewell to Faheem who is starting a position as Data Analyst at Munich RE!

1/19 – Congratulations to Ricardo, Matt, Mark, Sam, Pankaj, Jimmy, and Amir on the publication of their E. faecium paper in J. Med. Chem. Please check it out at: https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c01846

1/17 – We welcome Rutgers undergraduate Bruck Gebre to the group. He will work on machine learning models for chemical tool and drug discovery.
12/21 - Congratulations to Cristopher Lozada on being accepted into the Rutgers Pathway for Junior Scientist Program for the Spring 2024 semester.
12/7 - Congratulations to Ravi on his paper entitled “Linezolid does not improve bactericidal activity of rifampin-containing first-line regimens in animal models of TB”. This is part of a collaboration with Sanjay Jain’s lab at Hopkins. Please check it out here.

8/8/23 – The lab enjoys an outing at Cheesequake State Park. Is it odd that no one brought a cheesecake??

News/Archives

Contact Us

Joel S. Freundlich, Ph.D.
Professor
Department of Pharmacology and Physiology
Department of Medicine
Center for Emerging and Reemerging Pathogens
Rutgers University
Medical Sciences Building
I503 (office)/I507 (lab)
185 South Orange Avenue
Newark, NJ 07103

(609) 375-8643 (Google)
(973) 972-7165 (office)
(973) 972-1141 (fax)
E-mail: freundjs ~[a t]~ rutgers.edu

(replace the ~[a t]~ with a simple @, and remove the spaces)

Alternatively, you can reach us, ask questions, or show your support at the new Freundlich Lab blog.